About I Test
![](https://www.publichealth.columbia.edu/sites/default/files/styles/cola_media_200_16_9/public/media/images/2017-07/itest-about-2.jpg?itok=jDFN3nF1 200w, https://www.publichealth.columbia.edu/sites/default/files/styles/cola_media_260_16_9/public/media/images/2017-07/itest-about-2.jpg?itok=UFtgDC1B 260w, https://www.publichealth.columbia.edu/sites/default/files/styles/cola_media_320_16_9/public/media/images/2017-07/itest-about-2.jpg?itok=ZQgH0Tmp 320w, https://www.publichealth.columbia.edu/sites/default/files/styles/cola_media_400_16_9/public/media/images/2017-07/itest-about-2.jpg?itok=b-vRiOAj 400w, https://www.publichealth.columbia.edu/sites/default/files/styles/cola_media_520_16_9/public/media/images/2017-07/itest-about-2.jpg?itok=21PkIpUu 520w, https://www.publichealth.columbia.edu/sites/default/files/styles/cola_media_640_16_9/public/media/images/2017-07/itest-about-2.jpg?itok=kQKB6vcW 640w, https://www.publichealth.columbia.edu/sites/default/files/styles/cola_media_800_16_9/public/media/images/2017-07/itest-about-2.jpg?itok=C9ST_lXN 800w, https://www.publichealth.columbia.edu/sites/default/files/styles/cola_media_1040_16_9/public/media/images/2017-07/itest-about-2.jpg?itok=ANAsVYKg 1040w, https://www.publichealth.columbia.edu/sites/default/files/styles/cola_media_1280_16_9/public/media/images/2017-07/itest-about-2.jpg?itok=ntnvgGHj 1280w, https://www.publichealth.columbia.edu/sites/default/files/styles/cola_media_1600_16_9/public/media/images/2017-07/itest-about-2.jpg?itok=mOLJ3zAc 1600w)
Approximately 1 in 8 people in the US are unaware of having HIV, and an even greater number of people may be unaware of being infected with hepatitis C virus (HCV). The Centers for Disease Control and World Health Organization have called for expanding testing in settings where high-risk persons receive health services, including opioid addiction treatment.
“Project I test: Implementing HIV Testing in Opioid Treatment Programs” is a national research study funded by the National Institute on Drug Abuse and led by researchers at Columbia University Mailman School of Public Health, Johns Hopkins University and University of Miami. The study’s purpose is to evaluate the use of Practice Coaching to increase HIV testing or joint HIV/HCV testing and linkage to care at opioid treatment programs. Practice Coaching is a proven intervention that guides clinical practices towards implementing evidence-based improvements in patient care.
Fifty-one (51) eligible opioid treatment programs across the US will be invited to participate from a random sample selected from public data available from the National Survey of Substance Abuse Treatment Services (N-SSATS), an annual census of all public and private substance abuse treatment facilities in the United States. For more information, see the Clinical Trials website (#NCT03135886).